Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;94(3):1190-1195.
doi: 10.1002/jmv.27378. Epub 2021 Oct 14.

SARS-CoV-2 rapid antigen test in comparison to RT-PCR targeting different genes: A real-life evaluation among unselected patients in a regional hospital of Italy

Affiliations

SARS-CoV-2 rapid antigen test in comparison to RT-PCR targeting different genes: A real-life evaluation among unselected patients in a regional hospital of Italy

Davide Treggiari et al. J Med Virol. 2022 Mar.

Abstract

We assessed the performance of the Panbio rapid antigen detection (RAD) test for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and we compared it with the routine reverse transcriptase-polymerase chain reaction (RT-PCR)-based molecular test in a population of 4167 unselected patients admitted to IRCCS Sacro Cuore Don Calabria Hospital. Analysis stratified by cycling threshold (Ct ) value of SARS-CoV-2 gene targets indicated that antigen (Ag)-positive Ct values were significantly lower compared to Ag-negative values (p < 0.0001). Overall, we found discordance in 140, tested negative by RAD and positive by RT-PCR, and in 4 resulted positive by RAD and negative by RT-PCR. RAD test achieved a sensitivity and specificity of 66.82% and 99.89%, respectively. The positive predictive value was shown to be 97.87% while the negative predictive value was shown to be 97.62%. In our context, the RAD test showed a reliable diagnostic response in subjects that displayed high Ct values, corresponding to high viral load, while low ability was displayed to identify positive cases with medium-low Ct values, thus presenting low viral load and where confirmatory RT-PCR was needed. Our finding supports the use of the RAD test in real-life settings where a high volume of swabs is being processed but with caution when interpreting a positive test result in a low prevalence setting.

Keywords: Panbio™ COVID-19; RAD; RT-PCR; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

FIGURE 1
FIGURE 1
(A) Distribution of C t values by RAD tested positive and negative. Statistical analysis was performed by Student's t‐test (***p < 0.0001). (B, C) C t values in RAD+/RT‐PCR+ and in RAD−/RT‐PCR+ specimens, respectively. Data are presented as box and whisker plots, showing median (horizontal line), boxes representing the 25th to 75th percentiles, whiskers representing minimum and maximum values. ***p < 0.001, **p < 0.001 was determined by one‐way ANOVA. ANOVA, analysis of variance; RAD, rapid antigen detection; RT‐PCR, reverse transcriptase‐polymerase chain reaction
FIGURE 2
FIGURE 2
Comparison of C t values of SARS‐CoV‐2 RT‐PCR gene targets according to RAD result. Each dot plot represents an individual C t value. One‐way ANOVA was performed (***p < 0.0001). ANOVA, analysis of variance; RAD, rapid antigen detection; RT‐PCR, reverse transcriptase‐polymerase chain reaction; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2

References

    1. Fenollar F, Bouam A, Ballouche M, et al. Evaluation of the Panbio COVID‐19 rapid antigen detection test device for the screening of patients with COVID‐19. J Clin Microbiol. 2021;59(2):e02589. 10.1128/JCM.02589-20 - DOI - PMC - PubMed
    1. Mina MJ, Parker R, Larremore DB. Rethinking Covid‐19 test sensitivity—a strategy for containment. N Engl J Med. 2020;383:e120. 10.1056/NEJMp2025631 - DOI - PubMed
    1. Dinnes J, Deeks JJ, Adriano A, et al. Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database Syst Rev. 2020;8:CD013705. 10.1002/14651858.CD013705 - DOI - PMC - PubMed
    1. ECDC. Options for the use of rapid antigen tests for COVID‐19 in the EU/EEA and the UK; 2020
    1. World Health Organization. Antigen‐detection in the diagnosis of SARS‐CoV‐2 infection using rapid immunoassays interim guidance; 2020.

Publication types

Substances